Discussion of “A Hybrid Phase I‐II/III Clinical Trial Design Allowing Dose Re‐Optimization in Phase III” by Andrew G. Chapple and Peter F. Thall (Q5214490)
From MaRDI portal
scientific article; zbMATH DE number 7165178
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Discussion of “A Hybrid Phase I‐II/III Clinical Trial Design Allowing Dose Re‐Optimization in Phase III” by Andrew G. Chapple and Peter F. Thall |
scientific article; zbMATH DE number 7165178 |
Statements
Discussion of “A Hybrid Phase I‐II/III Clinical Trial Design Allowing Dose Re‐Optimization in Phase III” by Andrew G. Chapple and Peter F. Thall (English)
0 references
7 February 2020
0 references
clinical trial design
0 references
